Christoph Merten,
Principal Investigator,
European Molecular Biology Laboratory
Christoph A. Merten (merten@embl.de) studied biochemistry at the University of Frankfurt and obtained his PhD on directed evolution of retroviral vectors at the Paul Ehrlich Institute in Langen, Germany. Subsequently he did a postdoc at the MRC Laboratory of Molecular Biology in Cambridge (UK), focussing on in vitro compartmentalization techniques. In 2005 he moved to the Institut de Science et d'Ingénierie Supramoléculaires (ISIS) in Strasbourg, France, where he became a junior group leader in 2007. Christoph joined the European Molecular Biology Laboratory in Heidelberg, Germany, as a Principal Investigator in 2010, where his group focusses on miniaturizing biology and chemistry in microfluidic systems.
|
|
Living Droplets – Microfluidic Antibody and Vaccine Discovery at Very High ThroughputMonday, 6 March 2017 at 11:30  Add to Calendar ▼2017-03-06 13:59:002017-03-06 14:59:00Europe/LondonSession 2SELECTBIOenquiries@selectbiosciences.comThis presentation will discuss droplet based microfluidics for the direct screening of millions of primary murine (from spleen and bone marrow) and human (from blood) plasma cells. It will also discuss assays for antibody binding, inhibition of enzymatic drug targets, effect on target cells. Compatability with difficult targets such as GPCRs and the screening of vaccine candidates.
|
.gif){kind=logo}
